![](/img/cover-not-exists.png)
ND2 EVALUATIONS OF THE PRESCRIBED DAILY DOSES OF TRANSDERMAL FENTANYL AND TRANSDERMAL BUPRENORPHINE IN CANCERAND NON-CANCER PATIENTS IN GERMANY: RESULTS FROM A RETROSPECTIVE DATABASE ANALYSIS
G Haerdtl, U Niemann, MC Nuijten, B Poulsen NautrupVolume:
9
Year:
2006
Language:
english
DOI:
10.1016/s1098-3015(10)64379-3
File:
PDF, 68 KB
english, 2006